Characterization of cetuximab Fc/2 dimers by off-line CZE-MS

Analytica Chimica Acta

Volumn 908, Issue , 2016, Pages 168-176

  François, Yannis Nicolas ^a   Biacchi, Michael ^a   Said, Nassur ^a   Renard, Charly ^a   Beck, Alain ^b   Gahoual, Rabah ^a,c   Leize Wagner, Emmanuelle ^a  

^a UNIVERSITÉ DE STRASBOURG   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^c VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

Capillary electrophoresis mass spectrometry; Dimers; Monoclonal antibody; NanoElectrospray

Indexed keywords

AMINO ACIDS; CAPILLARY ELECTROPHORESIS; CHARACTERIZATION; DIMERS; ELECTROPHORESIS; GLYCOSYLATION; MASS SPECTROMETRY; MONOCLONAL ANTIBODIES; PROTEINS; SEPARATION; SPECTROMETRY;

ANALYTICAL METHOD; ANTIBODY-DRUG CONJUGATES; BIOLOGICAL SAMPLES; CAPILLARY ELECTROPHORESIS-MASS SPECTROMETRIES; CAPILLARY ZONE ELECTROPHORESIS; MONOCLONAL ANTIBODIES (MAB); NANOELECTROSPRAY; THERAPEUTIC APPLICATION;

ANTIBODIES;

CETUXIMAB; DIMER; LYSINE;

ARTICLE; CAPILLARY ZONE ELECTROPHORESIS; CARBOXY TERMINAL SEQUENCE; CHEMICAL INTERACTION; CHEMICAL STRUCTURE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; GLYCOSYLATION; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MOLECULAR WEIGHT; PH; PRIORITY JOURNAL; ULTRAVIOLET SPECTROSCOPY; CAPILLARY ELECTROPHORESIS; CHEMISTRY; DIMERIZATION; MASS SPECTROMETRY; PROCEDURES; VALIDATION STUDY;

CETUXIMAB; DIMERIZATION; ELECTROPHORESIS, CAPILLARY; MASS SPECTROMETRY;

EID: 84955686112     PISSN: 00032670     EISSN: 18734324     Source Type: Journal    
DOI: 10.1016/j.aca.2015.12.033     Document Type: Article

References (35)

1. Beck A., Wurch T., Bailly C., Corvaia N. Strategies and challenges for the next generation of therapeutic antibodies. Nat. Rev. Immunol. 2010, 10:345-352.
2. Reichert J.M. Marketed therapeutic antibodies compendium. mAbs 2012, 4:413-415.
3. Beck A., Diemer H., Ayoub D., Debaene F., Wagner-Rousset E., Carapito C., Van Dorsselaer A., Sanglier-Cianferani S. Analytical characterization of biosimilar antibodies and Fc-fusion proteins. Trac Trends Anal. Chem. 2013, 48:81-95.
4. Arnold J.N., Wormald M.R., Sim R.B., Rudd P.M., Dwek R.A. The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu. Rev. Immunol. 2007, 25:21-50.
5. Zhang Z.Q., Pan H., Chen X.Y. Mass spectrometry for structural characteization of therapeutic antibodies. Mass Spectrom. Rev. 2009, 28:147-176.
6. Ravetch J.V., Kinet J.P. Fc receptors. Annu. Rev. Immunol. 1991, 9:457-492.
7. Torres M., Casadevall A. The immunoglobulin constant region contributes to affinity and specificity. Trends Immunol. 2008, 29:91-97.
8. Braun A., Kwee L., Labow M., Alsenz J. Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon alpha (IFN-α) in normal and transgenic mice. Pharm. Res. 1997, 14:1472-1478.
9. Schellekens H. Bioequivalence and the immunogenicity of biopharmaceuticals. Nat. Rev. Drug. Discov. 2002, 1:457-462.
10. Wu H., Kroe-Barrett R., Singh S., Robinson A.S., Roberts C.J. Competing aggregation pathways for monoclonal antibodies. FEBS Lett. 2014, 588:936-941.
11. Andersen C.B., Manno M., Rischel C., Thorolfsson M., Martorana V. Aggregation of a multidomain protein: a coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress. Prot. Sci. 2010, 19:279-290.
12. Brummitt R.K., Nesta D.P., Chang L.Q., Chase S.F., Laue T.M., Roberts C.J. Nonnative aggregation of an IgG1 antibody in acidic conditions: part 1. unfolding, colloidal interactions, and formation of high-molecular-weight aggregates. J. Pharm. Sci. 2011, 100:2087-2103.
13. Beck A., Sanglier-Cianferani S., Van Dorsselaer A. Biosimilar, biobetter, and next generation antibody characterization by mass spectrometry. Anal. Chem. 2012, 84:4637-4646.
14. Beck A., Wagner-Rousset E., Ayoub D., Van Dorsselaer A., Sanglier-Cianférani S. Characterization of therapeutic antibodies and related products. Anal. Chem. 2013, 85:715-736.
15. Beck A., Debaene F., Diemer H., Wagner-Rousset E., Colas O., Dorsselaer A.V., Cianférani S. Cutting-edge mass spectrometry characterization of originator, biosimilar and biobetter antibodies. J. Mass Spectrom. 2015, 50:285-297.
16. Gahoual R., Biacchi M., Chicher J., Kuhn L., Hammann P., Beck A., Leize-Wagner E., Francois Y.N. Monoclonal antibodies biosimilarity assessment using transient isotachophoresis capillary zone electrophoresis-tandem mass spectrometry. Mabs 2014, 6:1464-1473.
17. Gahoual R., Busnel J.-M., Beck A., François Y.-N., Leize-Wagner E. Full antibody primary structure and microvariant characterization in a single injection using transient isotachophoresis and sheathless capillary electrophoresis-tandem mass spectrometry. Anal. Chem. 2014, 86:9074-9081.
18. Han X., Wang Y., Aslanian A., Bern M., Lavallee-Adam M., Yates J.R. Sheathless capillary electrophoresis-tandem mass spectrometry for top-down characterization of Pyrococcus furiosus proteins on a proteome scale. Anal. Chem. 2014, 86:11006-11012.
19. Sun L.L., Knierman M.D., Zhu G.J., Dovichi N.J. Fast top-down intact protein characterization with capillary zone electrophoresis-electrospray ionization tandem mass spectrometry. Anal. Chem. 2013, 85:5989-5995.
20. Zhao Y., Riley N.M., Sun L., Hebert A.S., Yan X., Westphall M.S., Rush M.J.P., Zhu G., Champion M.M., Medie F.M., Champion P.A.D., Coon J.J., Dovichi N.J. Coupling capillary zone electrophoresis with electron transfer dissociation and activated ion electron transfer dissociation for top-down proteomics. Anal. Chem. 2015, 87:5422-5429.
21. Biacchi M., Bhajun R., Saïd N., Beck A., François Y.N., Leize-Wagner E. Analysis of monoclonal antibody by a novel CE-UV/MALDI-MS interface. Electrophoresis 2014, 35:2986-2995.
22. Redman E.A., Batz N.G., Mellors J.S., Ramsey J.M. Integrated microfluidic capillary electrophoresis-electrospray ionization devices with online MS detection for the separation and characterization of intact monoclonal antibody variants. Anal. Chem. 2015, 87:2264-2272.
23. Biacchi M., Gahoual R., Said N., Beck A., Leize-Wagner E., François Y.-N. Glycoform separation and characterization of cetuximab variants by middle-up off-line capillary zone electrophoresis-UV/electrospray ionization-MS. Anal. Chem. 2015, 87:6240-6250.
24. Wenig K., Chatwell L., von Pawel-Rammingen U., Bjorck L., Huber R., Sondermann P. Structure of the streptococcal endopeptidase IdeS, a cysteine proteinase with strict specificity for IgG. P. Nat. Acad. Sci. U. S. A. 2004, 101:17371-17376.
25. Vincents B., von Pawel-Rammingen U., Bjorck L., Abrahamson M. Enzymatic characterization of the streptococcal endopeptidase, IdeS, reveals that it is a cysteine protease with strict specificity for IgG cleavage due to exosite binding. Biochem. 2004, 43:15540-15549.
26. Ayoub D., Jabs W., Resemann A., Evers W., Evans C., Main L., Baessmann C., Wagner-Rousset E., Suckau D., Beck A. Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques. Mabs 2013, 5:699-710.
27. Wu H., Truncali K., Ritchie J., Kroe-Barrett R., Singh S., Robinson A.S., Roberts C.J. Weak protein interactions and pH- and temperature-dependent aggregation of human Fc1. mAbs 2015, 7(6):1072-1083.
28. Shen Y.F., Smith R.D. High-resolution capillary isoelectric focusing of proteins using highly hydrophilic-substituted cellulose-coated capillaries. J. Microcolumn Sep. 2000, 12:135-141.
29. Liu H.C., Gaza-Bulseco G., Faldu D., Chumsae C., Sun J. Heterogeneity of monoclonal antibodies. J. Pharm. Sci. 2008, 97:2426-2447.
30. Raju T.S., Scallon B.J. Glycosylation in the Fc domain of IgG increases resistance to proteolytic cleavage by papain. Biochem. Biophys. Res. Co. 2006, 341:797-803.
31. Antes B., Amon S., Rizzi A., Wiederkum S., Kainer M., Szolar O., Fido M., Kircheis R., Nechansky A. Analysis of lysine clipping of a humanized Lewis-Y specific IgG antibody and its relation to Fc-mediated effector function. J. Chromatogr. B 2007, 852:250-256.
32. Gahoual R., Busnel J.M., Wolff P., Francois Y.N., Leize-Wagner E. Novel sheathless CE-MS interface as an original and powerful infusion platform for nanoESI study: from intact proteins to high molecular mass noncovalent complexes. Anal. Bioanal. Chem. 2014, 406:1029-1038.
33. Nettleton E.J., Sunde M., Lai Z.H., Kelly J.W., Dobson C.M., Robinson C.V. Protein subunit interactions and structural integrity of amyloidogenic transthyretins: evidence from electrospray mass spectrometry. J. Mol. Biol. 1998, 281:553-564.
34. Benesch J.L.P., Ruotolo B.T., Simmons D.A., Barrera N.P., Morgner N., Wang L.C., Helen R., Robinson C.V. Separating and visualisiing protein assemblies by means of preparative mass spectrometry and microscopy. J. Struct. Biol. 2010, 172:161-168.
35. Touboul D., Maillard L., Grasslin A., Moumne R., Seitz M., Robinson J., Zenobi R. How to deal with weak interactions in noncovalent complexes analyzed by electrospray mass spectrometry: cyclopeptidic inhibitors of the nuclear receptor coactivator 1-STAT6. J. Am. Soc. Mass Spectrom. 2009, 20:303-311.